Restricted accessResearch articleFirst published online 2022-9
Amplification of Positivity Therapy for Co-occurring Alcohol Use Disorder with Depression and Anxiety Symptoms: Pilot Feasibility Study and Case Series
Positive valence system dysregulation is a relatively unexplored transdiagnostic mechanism and potential treatment target underpinning alcohol use and anxiety and depression symptoms. The current study examined the feasibility and potential benefit of a behavioral intervention focused on amplification of positivity (AMP) with eight adults (five female) diagnosed with alcohol use disorder and clinically significant depression or anxiety (ClinicalTrials.gov: NCT04278365). AMP for alcohol use (AMP-A) was delivered in 11 individual sessions involving positive activity interventions integrated alongside psychoeducation and alcohol use monitoring. Case descriptions are provided to illustrate treatment implementation. Treatment credibility and acceptability, participant endorsement of the therapy, and homework compliance were rated moderate to high. Exploratory, intent-to-treat analyses suggested medium to large effect sizes for post-treatment improvements in alcohol use, depression, anxiety, and positive affect. Results provide initial evidence of feasibility and acceptability of AMP-A and will be useful for informing future randomized clinical trials to examine clinical efficacy.
BakerA. L.KavanaghD. J.Kay-LambkinF. J.HuntS. A.LewinT. J.CarrV. J.ConnollyJ. (2010). Randomized controlled trial of cognitive-behavioural therapy for coexisting depression and alcohol problems: Short-term outcome. Addiction, 105(1), 87–99. https://doi.org/10.1111/j.1360-0443.2009.02757.x
2.
BanyardV. L.PlanteE. G.MoynihanM. M. (2004). Bystander education: Bringing a broader community perspective to sexual violence prevention. Journal of Community Psychology, 32(1), 61–79.
3.
BatesD.MaechlerM.BolkerB.WalkerS. (2015). Fitting linear mixed-effects models using lme4. Journal of Statistical Software, 67(1), 1–48. https://doi.org/10.18637/jss.v067.i01
4.
BoschlooL.VogelzangsN.SmitJ. H.van den BrinkW.VeltmanD. J.BeekmanA. T.PenninxB. W. (2011). Comorbidity and risk indicators for alcohol use disorders among persons with anxiety and/or depressive disorders: Findings from the Netherlands Study of Depression and Anxiety (NESDA). Journal of Affective Disorders, 131(1–3), 233–242. https://doi.org/10.1016/j.jad.2010.12.014
5.
BroderickJ. E.DeWittE. M.RothrockN.CraneP. K.ForrestC. B. (2013). Advances in patient-reported outcomes: The NIH PROMIS measures. eGEMS, 1(1), 1015. https://doi.org/10.13063/2327-9214.1015
6.
CarrollK. M.KilukB. D. (2017). Cognitive behavioral interventions for alcohol and drug use disorders: Through the stage model and back again. Psychology of Addictive Behaviors, 31(8), 847.
7.
CellaD.RileyW.StoneA.RothrockN.ReeveB.YountS.AmtmannD.BodeR.BuysseD.ChoiS.CookK.DevellisR.DeWaltD.FriesJ. F.GershonR.HahnE. A.LaiJ. S.PilkonisP.RevickiD.… HaysR.; PROMIS Cooperative Group. (2010). The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. Journal of Clinical Epidemiology, 63(11), 1179–1194.
8.
ChoS. B.SuJ.KuoS. I.BucholzK. K.ChanG.EdenbergH. J.McCutcheonV. V.SchuckitM. A.KramerJ. R.DickD. M. (2019). Positive and negative reinforcement are differentially associated with alcohol consumption as a function of alcohol dependence. Psychology of Addictive Behaviors, 33(1), 58–68.
9.
CooperM. L.FroneM. R.RussellM.MudarP. (1995). Drinking to regular positive and negative emotions: A motivational model of alcohol use. Journal of Personality and Social Psychology, 69(5), 990–1005.
10.
CraskeM. G.MeuretA. E.RitzT.TreanorM.DourH.RosenfieldD. (2019). Positive affect treatment for depression and anxiety: A randomized clinical trial for a core feature of anhedonia. Journal of Consulting and Clinical Psychology, 87(5), 457–471. https://doi.org/10.1037/ccp0000396
11.
DaughtersS. B.MagidsonJ. F.AnandD.Seitz-BrownC. J.ChenY.BakerS. (2018). The effect of a behavioral activation treatment for substance use on post-treatment abstinence: A randomized controlled trial. Addiction, 113(3), 535–544. https://doi.org/10.1111/add.14049
12.
DevillyG. J. (2004). An approach to psychotherapy toleration: The Distress/Endorsement Validation Scale (DEVS) for clinical outcomes studies. Journal of Behavior Therapy and Experimental Psychiatry, 35(4), 319–336. https://doi.org/10.1016/j.jbtep.2004.08.001
13.
DevillyG. J.BorkovecT. D. (2000). Psychometric properties of the credibility/expectancy questionnaire. Journal of Behavior Therapy and Experimental Psychiatry, 31, 73–86. https://doi.org/10.1016/s0005-7916(00)00012-4
14.
DichterG. S.FelderJ. N.BizzellJ.ErnstM.SmoskiM. J. (2009). The effects of psychotherapy on neural responses to rewards in major depression. Biological Psychiatry, 66, 886–897.
15.
DiekhofE. K.FalkaiP.GruberO. (2008). Functional neuroimaging of reward processing and decision-making: A review of aberrant motivational and affective processing in addiction and mood disorders. Brain Research Reviews, 59(1), 164–184.
16.
DillonD. G.RossoI. M.PechtelP.KillgoreW. D.RauchS. L.PizzagalliD. A. (2014). Peril and pleasure: An rdoc-inspired examination of threat responses and reward processing in anxiety and depression. Depression and Anxiety, 31(3), 233–249. https://doi.org/10.1002/da.22202
17.
DimidjianS.DobsonK. S.KohlenbergR. J.GallopR.MarkleyD. K.AtkinsD. C.HollonS. D.SchmalingK. B.AddisM. E.McGlincheyJ. B.GollanJ. K.DunnerD. L.JacobsonN. S. (2006). Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology, 74(1), 658–670.
18.
DunnB. D.WidnallE.ReedN.OwensC.CampbellJ.KuykenW. (2019). Brining light into darkness: A multiple baseline mixed methods care series evaluation of augmented depression therapy (ADepT). Behaviour Research and Therapy, 120, 103418.
19.
FrankenI. H.RassinE.MurisP. (2007). The assessment of anhedonia in clinical and non-clinical populations: Further validation of the Snaith-Hamilton Pleasure Scale (SHAPS). Journal of Affective Disorders, 99(1–3), 83–89.
GrantB. F.ChouS. P.SahaT. D.PickeringR. P.KerridgeB. T.RuanW. J.HuangB.JungJ.ZhangH.FanA.HasinD. S. (2017). Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001-2002 to 2012-2013: Results from the National Epidemiologic Survey on alcohol and related conditions. JAMA Psychiatry, 74(9), 911–923.
22.
HayesS. C.LuomaJ. B.BondF. W.MasudaA.LillisJ. (2006). Acceptance and commitment therapy: Model, processes and outcomes. Behaviour Research and Therapy, 44(1), 1–25.
23.
HerbeckD. M.FitekD. J.SvikisD. S.MontoyaI. D.MarcusS. C.WestJ. C. (2005). Treatment compliance in patients with comorbid psychiatric and substance use disorders. American Journal on Addictions, 14(3), 195–207.
24.
HussongA. M.JonesD. J.SteinG. L.BaucomD. H.BoedingS. (2011). An internalizing pathway to alcohol use and disorder. Psychology of Addictive Behaviors, 25(3), 390–404. https://doi.org/10.1037/a0024519
25.
JacobsonN. S.DobsonK. S.TruaxP. A.AddisM. E.KoernerK.GollanJ. K.GortnerE.PrinceS. E. (1996). A component analysis of cognitive-behavioral treatment for depression. Journal of Consulting and Clinical Psychology, 64(2), 295–304. https://doi.org/10.1037//0022-006x.64.2.295
26.
JacobsonN. S.MartellC. R.DimidjianS. (2001). Behavioral activiation treatment for depression: Returning to contextual roots. Clinical Psychology: Science and Practice, 8(3), 255–270.
27.
KalivasP. W.VolkowN. D. (2005). The neural basis of addiction: A pathology of motivation and choice. American Journal of Psychiatry, 162(8), 1403–1413.
28.
KazantisN.DeaneF. P.RonanK. R. (2004). Assessing compliance with homework assignments: Review and recommendations for clinical practice. Journal of Clinical Psychology, 60(6), 627–641. https://doi.org/10.1002/jclp.10239
29.
KoobG. F.VolkowN. D. (2016). Neurobiology of addiction: A neurocircuitry analysis. The Lancet Psychiatry, 3(8), 760–773.
30.
KoszyckiD.ThakeJ.MavounzaC.DaoustJ. P.TaljaardM.BradwejnJ. (2016). Preliminary investigation of a mindfulness-based intervention for social anxiety disorder that integrates compassion meditation and mindful exposure. The Journal of Alternative and Complementary Medicine, 22(5), 363–374. https://doi.org/10.1089/acm.2015.0108
31.
LaiH. M. X.ClearyM.SitharthanT.HuntG. E. (2015). Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis. Drug and Alcohol Dependence, 154, 1–13.
32.
LeeR. M.DraperM.LeeS. (2001). Social connectedness, dysfunctional interpersonal behaviors, and psychological distress: Testing a mediator model. Journal of Counseling Psychology, 48(3), 310.
33.
LyubomirskyS.KingL.DienerE. (2005). The benefits of frequent positive affect: Does happiness lead to success?Psychological Bulletin, 131(6), 803–855.
34.
LyubomirskyS.SheldonK. M.SchkadeD. (2005). Pursuing happiness: The architecture of sustainable change. Review of General Psychology, 9(2), 111–131.
35.
MacKillopJ.KahlerC. W. (2009). Delayed reward discounting predicts treatment response for heavy drinkers receiving smoking cessation treatment. Drug and Alcohol Dependence, 104(3), 197–203.
36.
MagidsonJ. F.LiuS.-M.LejuezC.BlancoC. (2012). Comparison of the course of substance use disorders among individuals with and without generalized anxiety disorder in a nationally representative sample. Journal of Psychiatric Research, 46(5), 659–666.
37.
MagillM.RayL. A. (2009). Cognitive-behavioral treatment with adult alcohol and illicit drug users: A meta-analysis of randomized controlled trials. Journal of Studies on Alcohol and Drugs, 70(4), 516–527. https://doi.org/10.15288/jsad.2009.70.516
38.
MangiaficoS. (2020). rcompanion: Functions to support extension education program evaluation [Computer software]. R package version 2.3.25. https://CRAN.R-project.org/package=rcompanion
39.
MannK.KieferF.SmolkaM.GannH.WellekS.HeinzA.TeamP. S. R. (2009). Searching for responders to acamprosate and naltrexone in alcoholism treatment: Rationale and design of the PREDICT study. Alcoholism: Clinical and Experimental Research, 33(4), 674–683. https://doi.org/10.1111/j.1530-0277.2008.00884.x
40.
MarlattG. A.WitkiewitzK. (2002). Harm reduction approaches to alcohol use: Health promotion, prevention, and treatment. Addictive Behaviors, 27(6), 867–886. https://doi.org/10.1016/S0306-4603(02)00294-0
41.
MartinA.RiefW.KlaibergA.BraehlerE. (2006). Validity of the brief patient health questionnaire mood scale (PHQ-9) in the general population. General Hospital Psychiatry, 28(1), 71–77.
42.
Mee-LeeD. (2013). The ASAM criteria. American Society of Addiction Medicine.
43.
MilosevicI.LevyH. C.AlcoladoG. M.RadomskyA. S. (2015). The treatment acceptability/adherence scale: Moving beyond the assessment of treatment effectiveness. Cognitive Behavior Therapy, 44(6), 456–469. https://doi.org/10.1080/16506073.2015.1053407
44.
MooreR. C.ChattillionE. A.CeglowskiJ.HoJ.von KanelR.MillsP. J.ZieglerM. G.PattersonT. L.GrantI.MausbachB. T. (2013). A randomized clinical trial of Behavioral Activation (BA) therapy for improving psychological and physical health in dementia caregivers: Results of the pleasant events program (PEP). Behaviour Research and Therapy, 51(10), 623–632.
45.
MorleyK. C.BaillieA.LeungS.SannibaleC.TeessonM.HaberP. S. (2016). Is specialized integrated treatment for comorbid anxiety, depression and alcohol dependence better than treatment as usual in a public hospital setting?Alcohol and Alcoholism, 51(4), 402–409. https://doi.org/10.1093/alcalc/agv131
46.
MorrisS. E.CuthbertB. N. (2012). Research domain criteria: Cognitive systems, neural circuits, and dimensions of behavior. Dialouges in Clinical Neuroscience, 14(1), 29–37.
47.
NormanS. B.Hami CissellS.Means-ChristensenA. J.SteinM. B. (2006). Development and validation of an Overall Anxiety Severity and Impairment Scale (OASIS). Depression and Anxiety, 23(4), 245–249.
48.
PomerleauO. F.FagerstromK. O.MarksJ. L.TateJ. C.PomerleauC. S. (2003). Development and validation of a self-rating scale for positive- and negative-reinforcement smoking: The Michigan Nicotine Reinforcement Questionnaire. Nicotine & Tobacco Research, 5(5), 711–718.
49.
R Core Team. (2013). R: A language and environment for statistical computing. http://www.R-project.org/
50.
RandallC. L.ThomasS.ThevosA. K. (2001). Concurrent alcoholism and social anxiety disorder: A first step toward developing effective treatments. Alcoholism: Clinical and Experimental Research, 25(2), 210–220. https://www.ncbi.nlm.nih.gov/pubmed/11236835
RehmJ.MathersC.PopovaS.ThavorncharoensapM.TeerawattananonY.PatraJ. (2009). Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. The Lancet, 373(9682), 2223–2233. https://doi.org/10.1016/S0140-6736(09)60746-7
53.
RiperH.AnderssonG.HunterS. B.de WitJ.BerkingM.CuijpersP. (2014). Treatment of comorbid alcohol use disorders and depression with cognitive-behavioural therapy and motivational interviewing: A meta-analysis. Addiction, 109(3), 394–406. https://doi.org/10.1111/add.12441
54.
SalsmanJ. M.VictorsonD.ChoiS. W.PetermanA. H.HeinemannA. W.NowinskiC.CellaD. (2013). Development and validation of the positive affect and well-being scale for the neurology quality of life (Neuro-QOL) measurement system. Quality of Life Research, 22(9), 2569–2580. https://doi.org/10.1007/s11136-013-0382-0
55.
SannibaleC.TeessonM.CreamerM.SitharthanT.BryantR. A.SutherlandK.TaylorK.Bostock-MatuskoD.VisserA.Peek-O’LearyM. (2013). Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction, 108(8), 1397–1410. https://doi.org/10.1111/add.12167
56.
SheehanD. V. (2014). The mini-international neuropsychiatric interview, Version 7.0 for DSM-5 (MINI 7.0) [Computer software]. Medical Outcomes Systems.
57.
SheehanD. V.Harnett-SheehanK.RajB. A. (1996). The measurement of disability. International Clinical Psychopharmacology, 11, 89–95.
58.
SingletonE. G. (1997). Alcohol Craving Questionnaire, short-form (revised) (ACQ-SF-R). Background, scoring, and administration. Unpublished Research. Behavioral Pharmacology Research Unit (BPRU), Department of Psychiatry and Behavioral Sciences. The Johns Hopkins University School of Medicine.
59.
SobellL. C.SobellM. B. (1992). Timeline follow-back. In LittenR. Z.AllenJ. P. (Eds.), Measuring alcohol consumption (pp. 41–72). Humana Press.
60.
SzucsD.IoannidisJ. P. (2017). Empirical assessment of published effect sizes and power in the recent cognitive neuroscience and psychology literature. PLoS Biology, 15(3), e2000797. https://doi.org/10.1371/journal.pbio.2000797
61.
TaylorC. T.LyubomirskyS.SteinM. B. (2017). Upregulating the positive affect system in anxiety and depression: Outcomes of a positive activity intervention. Depression and Anxiety, 34(3), 267–280. https://doi.org/https://doi.org/10.1002/da.22593
62.
TaylorC. T.PearlsteinS. L.KakariaS.LyubomirskyS.SteinM. B. (2020). Enhancing social connectedness in anxiety and depression through amplification of positivity: Preliminary treatment outcomes and process of change. Cognitive Therapy and Research, 44(4), 788–800. https://doi.org/https://doi.org/10.1007/s10608-020-10102-7
63.
TaylorC. T.PearlsteinS. L.SteinM. B. (2020). A tale of two systems: Testing a positive and negative valence systems framework to understand social disconnection across anxiety and depressive disorders. Journal of Affective Disorders, 266, 207–214.
64.
TeessonM.SladeT.MillsK. (2009). Comorbidity in Australia: Findings of the 2007 National Survey of mental health and wellbeing. Australian & New Zealand Journal of Psychiatry, 43(7), 606–614. https://doi.org/10.1080/00048670902970908
65.
Thompson-HollandsJ.BentleyK. H.GallagherM. W.BoswellJ. F.BarlowD. H. (2014). Credibility and outcome expectancy in the unified protocol: Relationship to outcomes. Journal of Experimental Psychopathology, 5(1), 72–82. https://doi.org/10.5127/jep.033712
66.
TuckerJ. A.RothD. L.VignoloM. J.WestfallA. O. (2009). A behavioral economic reward index predicts drinking resolutions: Moderation revisited and compared with other outcomes. Journal of Consulting and Clinical Psychology, 77(2), 219.
67.
VenniroM.ZhangM.CaprioliD.HootsJ. K.GoldenS. A.HeinsC.MoralesM.EpsteinD. H.ShahamY. (2018). Volitional social interaction prevents drug addiction in rat models. Nature Neuroscience, 21(11), 1520–1529. https://doi.org/10.1038/s41593-018-0246-6
68.
VolkowN. D.WangG. J.FowlerJ. S.TomasiD.TelangF.BalerR. (2010). Addiction: Decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit. Bioessays, 32(9), 748–755. https://doi.org/10.1002/bies.201000042
69.
WatsonD.ClarkL. A. (1999). The PANAS-X: Manual for the positive and negative affect schedule-expanded form. Ames.
70.
Wolitzky-TaylorK.KrullJ.RawsonR.Roy-ByrneP.RiesR.CraskeM. G. (2018). Randomized clinical trial evaluating the preliminary effectiveness of an integrated anxiety disorder treatment in substance use disorder specialty clinics. Journal of Consulting and Clinical Psychology, 86(1), 81.
71.
World Health Organization. (2019). Global status report on alcohol and health 2018. World Health Organization.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
